Some families that reported independently adjusting insulin delivery settings expressed comfort with a “trial-and-error” approach to diabetes management, whereas those who preferred to rely on the clinical team were noted to be less interested in independently reviewing their data, possibly due to being overwhelmed with T1D management and/or the perception that adjusting medications is the responsibility of trained medical professionals. This evidence concerns the gene INS and diabetes mellitus.